The next-generation surgical device from Corcym was associated with consistent durability and positive safety data. For ...

A research group at Kyoto University has announced the results of a nationwide data comparison of in-hospital outcomes for ...

Corcym is touting positive mid-term data from a sub-analysis of its Perceval Plus sutureless aortic heart valve in its MANTRA ...

A minimalist approach to transcatheter aortic valve implantation (TAVI), without sedation, was noninferior to the standard approach for the primary outcome at 30 days, according to late-breaking ...

Corcym, a global medical device company dedicated to cardiac surgery, today announced that positive mid-term data from a sub-analysis of its Perceval Plus sutureless aortic heart valve as part of its ...

There is no clearly established strategy for the treatment of a patient with cardiomyopathy and a symptomatic aneurysm of the thoracic aorta. We report the successful use of an approach combining ...

When cardiologists thread a replacement heart valve through a patient’s femoral artery, they often focus on how narrow or ...

Explore Transcatheter Aortic Valve Implantation (TAVI), a minimally invasive procedure that replaces a diseased aortic valve through a catheter, offering an alternative to conventional open-heart ...

BRISBANE, Australia & MINNEAPOLIS--(BUSINESS WIRE)--Anteris Technologies Ltd, (Anteris or the Company) (ASX: AVR), a structural heart company developing DurAVR™ THV, a new class of biomimetic heart ...

The drumbeat of innovation in the heart valves space continues as companies pursue next-generation devices for easier implantation, to improve durability and to treat younger patients. Even though ...